Impaired erythrocyte deformability precedes vascular changes in experimental diabetes mellitus

Hormone and Metabolic Research

Volumn 36, Issue 3, 2004, Pages 142-147

  Diamantopoulos, E J ^a,c   Kittas, C ^b   Charitos, D ^b   Crigoriadou, M ^a   Ifanti, C ^a   Raptis, S A ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Blood rheology; Diabetic angiopathy; Erythrocyte deformability; Experimental diabetes

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY WALL; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; FLOW KINETICS; HISTOLOGY; IN VITRO STUDY; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR DISEASE;

ANIMALS; ARTERIES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DRUG ADMINISTRATION SCHEDULE; ERYTHROCYTE DEFORMABILITY; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; RHEOLOGY; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 1942440857     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814337     Document Type: Article

References (40)

1. Barnes AJ, Locke P, Scudder PR, Dormandy TL, Dormandy JA, Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet 1977; 2 (8042): 789-791
2. Sagel J, Colwell JA, Crook L, Laimins M. Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 1975; 82; 733-738
3. Baba Y, Kai M, Kamada T, Setoyama S, Otsuji S. Higher levels of erythrocyte membrane microviscosity in diabetes. Diabetes 1979; 28: 1138-1140
4. Schmid-Schönbein H, Volger E. Red-cell aggregation and red-cell deformability in diabetes. Diabetes 1976; 25 (Suppl 2); 897-902
5. Wautier JL, Paton RC, Wautier M-P, Pintigny D, Abadie E, Passa P, Caen JP. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 1981; 305: 237-242
6. McMillan DE, Utterback NG, La Puma J. Reduced erythrocyte deformability in diabetes. Diabetes 1978; 27: 895-901
7. Ernst E, Matrai A. Altered red and white blood cell rheology in type II diabetes. Diabetes 1986; 35: 1412-1415
8. Diamantopoulos EJ, Raptis S, Christodoulou MN, Moulopoulos SD. Impaired red blood cell deformability in diabetic angiopathy. The Royal Society of Medicine, London. International Congress and Symposium Series (1984); No. 77: 93-104
9. Diamantopoulos EJ, Raptis SA, Moulopoulos SD. Red blood cell deformability index in diabetic retinopathy. Horm Metab Res 1987; 19: 569-573
10. Diamantopoulos EJ, Raptis SA, Karaiskos K, Mandel R, Moulopoulos SD. Erythrozytendeformabilität bei koronarkranken mit und ohne Diabetes mellitus. Verhandl Deut Gesel Innere Med. J.F. Bergmann Verlag, München: (1981): 120-123
11. Wu TJ, Chuang LM, Tai TY. Erythrocyte deformability in diabetes mellitus. J Formosan Med Assoc 1989; 88: 240-243
12. Carandente O, Colombo R, Girardi AM, Margonato A, Pozza G. Role of red cell sorbitol as determinant of reduced erythrocyte filtrability in insulin dependent diabetics. Acta Diabetol Lat 1982; 19: 359-368
13. Robey C, Dasmahapatra A, Cohen MP, Suarez S. Sorbinil partially prevents decreased erythrocyte deformability in experimental diabetes mellitus. Diabetes 1997; 36: 1010-1013
14. Vague P, Juhan I. Red cell deformability, platelet aggregation and insulin action. Diabetes 1983; 32 (Suppl 2): 88-91
15. Prisco D, Paniccia R, Coppo M, Vanni D, Rogasi PG, Tramontana M, Abbate R, Gensini GF. Red blood cell lipid alterations in type II diabetes mellitus. Thromb Res 1989; 54: 751-758
16. Garnier M, Attali JR, Valensi P, Delatour-Hanss E, Gaudey F, Koutsouris D. Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism 1990; 39: 794-798
17. Bryszewska M, Szosland K. Association between the glycation of erythrocyte membrane proteins and membrane fluidity. Clin Biochem 1988; 21: 49-51
18. Brown C, Zhao Z, Alaro F, Chan S, Friedman E. Correction of erythrocyte deformability defect in ALX-induced diabetic rabbits after treatment with aminoguanidine. Diabetes 1993; 16: 590-593
19. Symeonidis A, Athanassiou G, Psiroyiannis A, Kyriazopoulou V, Kapatais-Zoumbos K, Missirlis Y, Zoumbos N. Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients. Clin Lab Haematol 2001; 23: 103-109
20. International Committee for Standardization in Haematology. Guidelines for measurement of blood viscosity and erythrocyte deformability. Clin Hemorheol 1986; 6: 439-453
21. Heilmann L, Schmid-Schönbein H. Ein methodischer Beitrag zur Messung der Erythrozytenverformbarkeit. Klin Wochenschr 1981; 59: 181-185
22. Chien S. Filterability and other methods of approaching red cell deformability. Determinants of blood viscosity and red cell deformability. Scand J Clin Lab Invest Suppl 1981; 156: 7-12
23. Koutsouris D. Etude des facteurs physiologiques de la deformabilité érythrocytaire. Thèse pour le Doctorat en Génie Biologique et Médical (Bioméchanique) Université de Paris XIII, U.E.R. Biomédicale de Bobigny, 1982
24. Juhan I, Vague P, Buonocore M, Moulin JP, Calas MF, Vialettes B, Verdott JJ. Effect of insulin on erythrocyte deformability and platelet aggregation. Scand J Clin Lab Invest Suppl 1981; 156: 159-164
25. Juhan I, Vague P, Buonocore M, Moulin JP, Jouve R, Moulin J, Vialettes B. Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet 1982; 1 (8271): 535-537
26. Voisin P, Louis J, Vaillant G, Kollop SN, Gaillard S, Derby G, Stoltz J, Drouin P. Insulin has no influence in vitro on haemorheological parameters measured in poorly controlled diabetic patients. Clin Haemorheol 1983; 3: 268-271
27. Santini MT, Indovina PL, Simmons JR, Peterson SW. Human erythrocyte insulin receptor down-regulation is accompanied by a transient decrease in membrane order. Biochim Biophys Acta 1990; 1054: 333-336
28. +-ATPase activity in type I (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetologia 1986; 29: 623-628
29. +-ATPase activity in synergism with neuropeptide Y. Diabetologia 1996; 39: 199-205
30. +-ATPaSe activity of renal tubule segments. Diabetologia 1998; 41: 287-291
31. Kunt T, Schneider S, Pfützner A, Goitum K, Engelbach M, Schauf B, Beyer J, Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type I diabetes mellitus. Diabetologia 1999; 42: 465-471
32. Mavrikakis ME, Sfikakis PP, Kontoyannis DD, Horti M, Kittas C, Koutras DA, Raptis SA. Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study. Exp Clin Endocrinol Diabetes 1998; 106: 35-40
33. Rumble JR, Cooper ME, Soulis T, Cox A, Wu L, Youssef S, Jasik M, Jerums G, Gilbert RE. Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J Clin Invest 1997; 99: 1016-1027
34. Moore SA, Bohlen HG, Miller BG, Evan AP. Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats. Blood Vessels 1985; 22: 265-277
35. Reinila A. Long-term effects of untreated diabetes on the arterial wall in rat. An ultrastructural study. Diabetologia 1981; 20: 205-212
36. Vranes D, Cooper ME, Dilley RJ. Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res 1999; 57: 8-18
37. Jandeleit-Dahm K, Hannan KM, Farrelly CA, Allen TJ, Rumble JR, Gilbert RE, Cooper ME, Little PJ. Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition. Circ Res 2000; 87: 1133-1140
38. Bohlen HG, Hankins KD. Early arteriolar and capillary changes in streptozotocin-induced diabetic rats and intraperitoneal hyperglycaemic rats. Diabetologia 1982; 22: 344-348
39. Wehner H, Nelischer G. Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats. Virchows Arch A Pathol Anat Histopathol 1991; 419: 231-235
40. Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy. The haemodynamic view. Am J Med 1986; 80: 443-453